Type
|
Public |
---|---|
Traded as |
|
Industry | Healthcare |
Founded | 1984 |
Headquarters | Birmingham, Alabama |
Key people
|
Mark Tarr (President and CEO) Douglas E. Coltharp (CFO) Barbara Jacobsmeyer (COO) |
Products | Rehabilitation Home Health Hospice |
Revenue | $3.71 billion USD (2016) |
Number of employees
|
36,500 (2016) |
Website | healthsouth |
HealthSouth Corporation, based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. HealthSouth can be found on the web at www.healthsouth.com. HealthSouth states that its "hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations"; and that subsidiary Encompass "provides a comprehensive range of Medicare-certified home nursing services to adult patients and, in some markets, in-home hospice services and home care services for pediatric patients with severe medical conditions".
HealthSouth was involved in a corporate accounting scandal in which its founder, chairman, and chief executive officer, Richard M. Scrushy, was accused of directing company employees to falsely report grossly exaggerated company earnings in order to meet stockholder expectations.
At the company's height in 2003, it recorded nearly $4.5 billion in revenue, dominated the rehabilitation, surgery and diagnostic services market and employed more than 60,000 people at 2,000 facilities in every state of the U.S. along with its facilities in the United Kingdom, Canada, Australia, Puerto Rico and Saudi Arabia. The company was the largest publicly listed healthcare company in the United States based on the number of locations and the third based on revenue.
By mid- to late 2006, HealthSouth, which never had to file for Chapter 11 Bankruptcy Protection, completed its recovery and relisted its stock on the New York Stock Exchange under the symbol HLS. The company currently operates one division: inpatient rehabilitation. The company formerly operated an outpatient rehabilitation, surgery center and diagnostics division. The company also previously owned and operated several acute care hospitals that specialized in orthopedics, but sold all of those hospitals by 2006. The former outpatient division also operated an occupational medicine division until 2001, when it was sold. HealthSouth also sold its Long-term acute care facilities in May 2011. The long-term hospitals contributed around $200 million in revenue.
HealthSouth was incorporated in Birmingham, Alabama as a Delaware company on February 22, 1984 as Amcare, Inc. by its founder Richard M. Scrushy. The company opened its first facility in Little Rock, Arkansas and one in Birmingham later that year. In 1985 the company changed its name to HealthSouth Rehabilitation Corporation. In 1986 the company went public with its IPO on the NASDAQ Stock Exchange under the ticker symbol HSRC. At the end of the company's last investor roadshow presentation in New York City before its IPO, Scrushy received a standing ovation from the investment bankers in attendance, an extreme rarity. In September 1988 the company moved to the New York Stock Exchange and became listed under the symbol HRC. By 1990 the company had expanded to 50 facilities across the US. HealthSouth finished out 1992 with $400 million in annual revenue. In 1993 the company made its first large acquisition when it bought 28 hospitals and 45 outpatient rehabilitation facilities from National Medical Enterprise for around $300 million in cash. The acquisition doubled the company's annual revenue to $1 billion and also made HealthSouth the nation's largest provider of rehabilitative care. In 1994, HealthSouth further expanded when it announced it would buy fellow Birmingham-based ReLife for $180 million in stock.
Throughout the mid-1990s, HealthSouth expanded rapidly through mergers and acquisitions. In 1995 the company changed its name to HealthSouth Corporation to better reflect its diversified interests in healthcare. On August 31, 1995 HealthSouth CEO Richard Scrushy announced that HealthSouth was going to build a new headquarters on US Highway 280 in Birmingham. The new corporate campus was to be built on 85 acres (340,000 m) of land that the company had bought from Southern Company earlier that year. The corporate campus plans included a five-story headquarters building with a connecting conference center and parking deck.
In January 1995 the company entered the surgery center business with its $155 million acquisition of Surgical Health Corporation. One month later the company acquired Novacare's entire rehabilitational hospital business for $215 million in cash. In 1996 the company expanded into diagnostics with its purchase of Health Images Inc. In the beginning of 1996 the company adopted the slogan "The Healthcare Company of the 21st Century". Less than a year later the company adopted the "H" logo as its corporate identity. HealthSouth made its largest acquisition yet when it purchased Horizon/CMS for $1.8 billion in 1997. A few months later after the acquisition, HealthSouth sold the long-term care assets of Horizon/CMS it did not need to Integrated Health Services for $1.15 billion in cash. HealthSouth along with many Healthcare publications called this the "deal of the century". Also in February 1997 the company finally moved into its new corporate headquarters. The headquarters building itself contained a company store and museum. HealthSouth continued on its acquisition spree through 1999 by purchasing the majority of Columbia/HCA's surgical division.
In 2001 the company announced it would, along with Oracle Corporation, build the world's first all-digital hospital on its corporate campus. The 13 story structure was meant as a replacement for its aging HealthSouth Medical Center in downtown Birmingham. Construction began soon after on the new HealthSouth Medical Center.
The first of HealthSouth's accounting problems surfaced in late 2002 after CEO Richard M. Scrushy sold $75 million in stock several days before the company posted a large loss. HealthSouth was accused by the U.S. Securities and Exchange Commission (SEC) of an accounting scandal where the company's earnings were falsely inflated by $1.4 billion. In 1996, Scrushy allegedly instructed the company's senior officers and accountants to falsify company earnings reports in order to meet investor expectations and control the price of the company's stock. The fraud continued for seven years. In certain fiscal years, the company's income was overstated by as much as 4700%. The $1.4 billion represents more than 10% of the company's total assets. At one point, the company's corporate taxes—based on its fraudulent earnings—were higher than its actual earnings.
In 1998, HealthSouth was accused of violation of the Securities Exchange Act by failing to disclose negative trends and misrepresenting company's financial information.
In March 2003, HealthSouth's CEO Richard M. Scrushy was charged with the accounting fraud and the SEC announced it was investigating whether Scrushy's stock sell was related to HealthSouth posting a large loss. HealthSouth hired an outside law firm to review Scrushy's stock sale, with the firm concluding that the sale and profit loss were not related, although this did not take the company off the SEC's radar. On the evening of March 18, 2003 FBI agents executed search warrants at the company's headquarters after the company's Chief Financial Officer William Owens agreed to wear a wire in a failed attempt to get Scrushy to talk about the fraud.
In June 2005, Scrushy was acquitted on all 36 of the accounting fraud counts against him, most notably one count in violation of the Sarbanes-Oxley Act. However, four years later, he was sued for fraud by HealthSouth investors and ordered to repay his company $2.8 billion.
Following the raid at the company's corporate headquarters, the board of directors held an emergency meeting to discuss what actions needed to be taken. One of the first actions was the termination of Richard Scrushy as Chairman and CEO, and Bill Owens as CFO. Robert P. May was elected as interim CEO and Joel C. Gordon as Chairman. Another issue that was immediately addressed by the board was the means by which it obtain the cash for interest payments of senior bonds and principal payments due on a $344 million convertible bond. The board agreed that the company's cash flow problems were too great to tackle on its own. At the advice of its lender JPMorgan Chase, the company hired restructuring firm Alvarez and Marsal to bring its finances in order and immediately appointed Bryan Marsal Chief Restructuring Officer. By the end of 2003, the company had most of its finances reorganized and was able to avoid Chapter 11 bankruptcy.
Efforts were made at the corporate headquarters to eradicate all signs of the prior existence of Scrushy within the company. The board removed Scrushy's name from the conference center, closed the company store and museum and opened the fifth floor executive offices to all employees, which, during Scrushy's tenure, had been kept away. The board also sold all but a few of the company's eleven corporate jets, which included a Gulfstream V and a Sikorsky S-76 C+ helicopter. In an effort to save money, the company halted construction of its Digital Hospital, for which building costs had doubled, to $400 million. On May 10, 2004, Jay Grinney was chosen by the board as the company's permanent CEO. Soon after Grinney's appointment, the company moved forward with its goal of again becoming a current filer with the SEC. By doing so, the company restated earnings from 2000 to 2003. The company also sold or closed many underperforming facilities, including its medical center division, in its effort to return to profitabiity.
On May 15, 2006, the company completed its goal of once again becoming a current filer with the SEC when it filed its first quarter 2006 financial result. It was the first time the company had filed a 10-Q since its accounting scandal began. On August 14, 2006 the company unveiled its restructuring plan which included the sell, spin-off or other disposition of its surgery, outpatient, and diagnostic divisions, along with a 1-for-5 reverse stock split, to coincide with its relisting on the New York Stock Exchange under the symbol HLS. The reverse stock split was approved by stock holders at a special meeting at the company's corporate headquarters on October 18, 2006. The last step in HealthSouth's recovery from its accounting scandal occurred on October 26, 2006 when it was again relisted on the New York Stock Exchange.
On January 29, 2007 the company announced it would sell its more than 600 outpatient centers to Select Medical Corporation for $245 million in cash. The transaction was completed on May 1, 2007.
On March 26, 2007, HealthSouth announced it would sell its surgery center division to private investment partnership TPG Capital for $920 million in cash and equity interest in the newly formed company worth between $25 to $30 million. The surgery center division comprised 139 outpatient surgery centers and three surgical hospitals. It was also announced that the new surgery center company would remain headquartered in Birmingham. The transaction was completed on June 30, 2007 with the creation of Surgical Care Affiliates.
On April 29, 2007, HealthSouth announced a definitive agreement to sell its diagnostic division to the Gores Group for $47.5 million. It was also announced that the newly formed company was to remain in Birmingham. The transaction was completed on July 31, 2007 with Diagnostic Health Corporation being formed.
In July 2010, HealthSouth gave the American Cancer Society of Alabama the black V-12 2000 BMW 750iL, a bullet-proof sedan that HealthSouth purchased for security reasons under former CEO Richard Scrushy. Scrushy bought the car from HealthSouth in 2003 after an accounting scandal broke. Scrushy also owned a maroon 2000 bullet-proof V-12 BMW 750iL that was sold in 2009 by HealthSouth as part of a civil judgment against Scrushy. In 2009, HealthSouth had obtained ownership of Scrushy's black 2000 BMW 750iL.
2016-06-27 | Downgrade | Barclays | Equal Weight to Underweight | $45.00 to $42.00 |
2016-06-27 | Downgrade | Barclays PLC | Equal Weight to Underweight | $45.00 to $42.00 |
2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
2016-04-29 | Boost Price Target | Mizuho | Buy | $40.00 to $47.00 |
2016-04-28 | Boost Price Target | Barclays | Equal Weight | $39.00 to $45.00 |
2016-02-25 | Lower Price Target | Susquehanna | Positive | $50.00 to $42.00 |
2016-01-11 | Reiterated Rating | Mizuho | Buy | $40.00 |
2015-11-06 | Lower Price Target | Wedbush | Neutral | $51.00 to $45.00 |
2015-11-02 | Lower Price Target | JMP Securities | Market Outperform | $54.00 to $44.00 |
2015-10-30 | Lower Price Target | RBC Capital | $51.00 to $45.00 | |
2015-10-30 | Reiterated Rating | Raymond James | Outperform | $51.00 to $42.00 |
2015-10-30 | Reiterated Rating | Barclays | Equal Weight | $42.00 to $39.00 |
2015-10-30 | Lower Price Target | Royal Bank Of Canada | $51.00 to $45.00 | |
2015-10-30 | Reiterated Rating | Raymond James Financial Inc. | Outperform | $51.00 to $42.00 |
2015-10-29 | Downgrade | Stifel Nicolaus | Buy to Hold | $52.00 |
2015-10-29 | Lower Price Target | Mizuho | Buy | $50.00 to $40.00 |
2015-10-08 | Lower Price Target | Barclays | Equal Weight | $46.00 to $42.00 |
2015-07-31 | Boost Price Target | RBC Capital | Outperform | $47.00 to $51.00 |
2015-07-30 | Boost Price Target | Stifel Nicolaus | Buy | $51.00 to $52.00 |
2015-07-07 | Reiterated Rating | SunTrust | Buy | $54.00 |
2015-07-07 | Reiterated Rating | SunTrust Banks Inc. | Buy | $54.00 |
2015-07-02 | Upgrade | JMP Securities | Market Perform to Outperform | $54.00 |
2015-06-25 | Reiterated Rating | Deutsche Bank | Hold | $45.00 to $48.00 |
2015-06-25 | Reiterated Rating | Deutsche Bank AG | Hold | $45.00 to $48.00 |
2015-06-12 | Boost Price Target | Deutsche Bank | Hold | $45.00 to $48.00 |
2015-06-10 | Initiated Coverage | Wedbush | Neutral | $46.00 |
2015-02-26 | Boost Price Target | Barclays | Equal Weight | $42.00 to $46.00 |
2015-02-25 | Boost Price Target | Mizuho | Buy | $47.00 to $50.00 |
2015-01-20 | Boost Price Target | Mizuho | Buy | $45.00 to $47.00 |
2015-01-08 | Lower Price Target | Barclays | Equal Weight | $44.00 to $42.00 |
2014-12-17 | Upgrade | Raymond James | Market Perform to Outperform | |
2014-10-29 | Reiterated | RBC Capital Mkts | Outperform | $41 to $46 |
2014-10-29 | Boost Price Target | RBC Capital | Outperform | $41.00 to $46.00 |
2014-09-08 | Boost Price Target | Susquehanna | $45.00 to $47.00 | |
2014-07-31 | Boost Price Target | RBC Capital | Outperform | $37.00 to $41.00 |
2014-07-30 | Reiterated Rating | Barclays | Equal Weight | $36.00 to $44.00 |
2014-07-29 | Boost Price Target | Stifel Nicolaus | Buy | $38.00 to $41.00 |
2014-07-29 | Boost Price Target | Mizuho | Buy | $42.00 to $45.00 |
2014-04-29 | Reiterated Rating | Mizuho | Buy | $42.00 |
2014-04-28 | Lower Price Target | CRT Capital | Buy | $41.00 to $39.00 |
2014-04-01 | Initiated Coverage | Barclays | Equal Weight | $36.00 |
2014-01-06 | Downgrade | Raymond James | Outperform to Market Perform | |
2013-11-22 | Reiterated Rating | Stifel Nicolaus | Buy | $38.00 to $39.00 |
2013-11-20 | Boost Price Target | Susquehanna | Positive | $37.00 to $40.00 |
2013-10-30 | Boost Price Target | RBC Capital | Outperform | $34.00 to $37.00 |
2013-10-30 | Boost Price Target | Mizuho | Buy | $39.00 to $42.00 |
2013-10-30 | Boost Price Target | Deutsche Bank | Hold | $33.00 to $36.00 |
2013-10-29 | Boost Price Target | CRT Capital | Buy | $37.00 to $41.00 |
2013-08-16 | Reiterated | Mizuho | Buy | $36 to $39 |
2013-07-26 | Reiterated | Mizuho | Buy | $30 to $36 |
2013-03-26 | Resumed | Stifel | Buy | $29 |
2012-07-03 | Initiated | UBS | Buy | $30 |
2012-02-27 | Reiterated | Barclays Capital | Overweight | $22 to $26 |
2010-05-17 | Reiterated | Caris & Company | Buy | $22 to $26 |
2016-06-27 | Downgrade | Barclays | Equal Weight to Underweight | $45.00 to $42.00 |
2016-06-27 | Downgrade | Barclays PLC | Equal Weight to Underweight | $45.00 to $42.00 |
2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
2016-04-29 | Boost Price Target | Mizuho | Buy | $40.00 to $47.00 |
2016-04-28 | Boost Price Target | Barclays | Equal Weight | $39.00 to $45.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HLS 30 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 5.47M |
BlackRock Institutional Trust Company, N.A. | 2.71M |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 2.37M |
BlackRock Investment Management, LLC | 0.60M |
GW CAPITAL INC | 0.29M |
MANAGED ACCOUNT ADVISORS LLC | 0.22M |
AHL Partners LLP | 0.21M |
Hurley Capital, LLC | 0.19M |
CAPSTONE ASSET MANAGEMENT CO | 0.14M |
RUSSELL FRANK CO/ | 0.11M |
BLACKROCK ADVISORS LLC | 77953 |
BlackRock Group LTD | 71703 |
EverPoint Asset Management, LLC | 50000 |
LOMBARDIA CAPITAL PARTNERS LLC | 46217 |
Cantab Capital Partners LLP | 40562 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
GRINNEY JAY Pres & Chief Executive Officer | 1.40% (1231767) | EGN / HLS / |
Tarr Mark J EVP and COO | 0.33% (291963) | HLS / |
Whittington John P EVP, Gen. Counsel & Secretary | 0.23% (202094) | HLS / |
COLTHARP DOUGLAS E EVP, Chief Financial Officer | 0.14% (124407) | ARCC / HLS / UA / |
Clohan Dexanne B Chief Medical Officer | 0.12% (109120) | HLS / |
CHIDSEY JOHN | 0.12% (107971) | HLS / NCLH / |
Levy Cheryl B. Chief Human Resources Officer | 0.11% (99504) | HLS / |
HANSON JON F | 0.10% (88770) | HLS / |
SHAW L EDWARD JR | 0.10% (87595) | HLS / MSA / |
Fay Edmund Sr. Vice Pres. and Treasurer | 0.09% (82845) | HLS / |
Price Andrew L Chief Accounting Officer | 0.08% (74465) | HLS / |
MAUPIN JOHN E JR D D S | 0.08% (70284) | HLS / LPNT / RF / |
ELSON CHARLES M | 0.08% (69744) | BOBE / HLS / |
CORRELL DONALD L | 0.08% (68370) | HLS / NJR / |
HIGDON LEO I JR | 0.08% (67540) | CFG / EV / HLS / |
CURL YVONNE M | 0.08% (67107) | HLS / |
Jacobsmeyer Barbara Ann EVP, Operations | 0.04% (34067) | HLS / |
Darby John Patrick EVP, Gen Counsel & Secretary | 0.03% (27217) | HLS / |
KATZ LESLYE G | 0.03% (23554) | HLS / ICFI / |
HERMAN JOAN E | 0.02% (21168) | CVG / HLS / MRVC / |
Charbonneau Elissa Joy Chief Medical Officer | 0.02% (16933) | HLS / |